Utilization of Cervical Cancer Screening Services and Trends in Screening Positivity Rates in a 'Screen-And-Treat' Program Integrated with HIV/AIDS Care in Zambia

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Mwanahamuntu, Mulindi H ^a,b   Sahasrabuddhe, Vikrant V ^c   Blevins, Meridith ^c   Kapambwe, Sharon ^a   Shepherd, Bryan E ^c   Chibwesha, Carla ^a,d   Pfaendler, Krista S ^e   Mkumba, Gracilia ^b   Vwalika, Belington ^b   Hicks, Michael L ^f   Vermund, Sten H ^c   Stringer, Jeffrey S A ^a,b,d   Parham, Groesbeck P ^a,b,d  

^a CENTRE FOR INFECTIOUS DISEASE RESEARCH IN ZAMBIA   (Zambia)

^b UNIVERSITY TEACHING HOSPITAL   (Zambia)

^c VANDERBILT UNIVERSITY   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

^e UNIVERSITY OF CINCINNATI   (United States)

^f Michigan Cancer Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CANCER SCREENING; CLINICAL DECISION MAKING; CLINICAL EXAMINATION; CONTROLLED STUDY; DEMOGRAPHY; DIGITAL CERVICOGRAPHY; DIGITAL IMAGING; FEMALE; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTEGRATED HEALTH CARE SYSTEM; MAJOR CLINICAL STUDY; MEDICAL EDUCATION; NURSE; PATIENT CARE; QUALITY CONTROL; TELEMEDICINE; TREND STUDY; UTERINE CERVIX CANCER; ZAMBIA;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; DEMOGRAPHY; EARLY DETECTION OF CANCER; FEMALE; HIV SEROPOSITIVITY; HUMANS; LOGISTIC MODELS; MULTIVARIATE ANALYSIS; PROBABILITY; UTERINE CERVICAL NEOPLASMS; ZAMBIA;

EID: 84884255186     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074607     Document Type: Article

References (33)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer.
2. Gakidou E, Nordhagen S, Obermeyer Z, (2008) Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities. PLoS Med 5: e132.
3. Blumenthal PD, Gaffikin L, Deganus S, Lewis R, Emerson M, et al. (2007) Cervical cancer prevention: safety, acceptability, and feasibility of a single-visit approach in Accra, Ghana. Am J Obstet Gynecol 196: 407 e401-408; discussion 407 e408-409.
4. Gaffikin L, Blumenthal PD, Emerson M, Limpaphayom K, (2003) Safety, acceptability, and feasibility of a single-visit approach to cervical-cancer prevention in rural Thailand: a demonstration project. Lancet 361: 814-820.
5. Sankaranarayanan R, Boffetta P, (2010) Research on cancer prevention, detection and management in low- and medium-income countries. Ann Oncol 21: 1935-1943.
6. Sankaranarayanan R, Esmy PO, Rajkumar R, Muwonge R, Swaminathan R, et al. (2007) Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial. Lancet 370: 398-406.
7. Firnhaber C, Mayisela N, Mao L, Williams S, Swarts A, et al. (2013) Validation of cervical cancer screening methods in HIV positive women from Johannesburg South Africa. PLoS One 8: e53494.
8. Sahasrabuddhe VV, Parham GP, Mwanahamuntu MH, Vermund SH, (2012) Cervical cancer prevention in low- and middle-income countries: feasible, affordable, essential. Cancer Prev Res (Phila) 5: 11-17.
9. Belhadj H, Rasanathan JJ, Denny L, Broutet N (2013) Sexual and reproductive health and HIV services: Integrating HIV/AIDS and cervical cancer prevention and control. Int J Gynaecol Obstet.
10. Mwanahamuntu MH, Sahasrabuddhe VV, Kapambwe S, Pfaendler KS, Chibwesha C, et al. (2011) Advancing cervical cancer prevention initiatives in resource-constrained settings: insights from the Cervical Cancer Prevention Program in Zambia. PLoS Med 8: e1001032.
11. Denny LA, Franceschi S, de Sanjose S, Heard I, Moscicki AB, et al. (2012) Human papillomavirus, human immunodeficiency virus and immunosuppression. Vaccine 30Suppl 5: F168-174.
12. Franceschi S, Ronco G, (2010) The prevention of cervical cancer in HIV-infected women. AIDS 24: 2579-2580.
13. Ramogola-Masire D, de Klerk R, Monare B, Ratshaa B, Friedman HM, et al. (2012) Cervical cancer prevention in HIV-infected women using the "see and treat" approach in Botswana. J Acquir Immune Defic Syndr 59: 308-313.
14. Moon TD, Silva-Matos C, Cordoso A, Baptista AJ, Sidat M, et al. (2012) Implementation of cervical cancer screening using visual inspection with acetic acid in rural Mozambique: successes and challenges using HIV care and treatment programme investments in Zambezia Province. J Int AIDS Soc 15: 17406.
15. Horo A, Jaquet A, Ekouevi DK, Toure B, Coffie PA, et al. (2012) Cervical cancer screening by visual inspection in Cote d'Ivoire, operational and clinical aspects according to HIV status. BMC Public Health 12: 237.
16. Huchko MJ, Bukusi EA, Cohen CR, (2011) Building capacity for cervical cancer screening in outpatient HIV clinics in the Nyanza province of western Kenya. Int J Gynaecol Obstet 114: 106-110.
17. Mwanahamuntu MH, Sahasrabuddhe VV, Stringer JS, Parham GP (2008) Integrating cervical cancer prevention in HIV/AIDS treatment and care programmes. Bull World Health Organ 86: D-E.
18. Mahy M, Garcia-Calleja JM, Marsh KA, (2012) Trends in HIV prevalence among young people in generalised epidemics: implications for monitoring the HIV epidemic. Sex Transm Infect 88Suppl 2: i65-75.
19. Parham GP, Mwanahamuntu MH, Pfaendler KS, Sahasrabuddhe VV, Myung D, et al. (2010) eC3-a modern telecommunications matrix for cervical cancer prevention in Zambia. J Low Genit Tract Dis 14: 167-173.
20. Parham GP, Mwanahamuntu MH, Sahasrabuddhe VV, Westfall AO, King KE, et al. (2010) Implementation of cervical cancer prevention services for HIV-infected women in Zambia: measuring program effectiveness. HIV Therapy 4: 713-722.
21. Pfaendler KS, Mwanahamuntu MH, Sahasrabuddhe VV, Mudenda V, Stringer JS, et al. (2008) Management of cryotherapy-ineligible women in a "screen-and-treat" cervical cancer prevention program targeting HIV-infected women in Zambia: lessons from the field. Gynecol Oncol 110: 402-407.
22. Fay MP, Proschan MA, (2010) Wilcoxon-Mann-Whitney or t-test? On assumptions for hypothesis tests and multiple interpretations of decision rules. Stat Surv 4: 1-39.
23. Little RJA, Rubin DB (2002) Statistical analysis with missing data. Hoboken, N.J.: Wiley. xv, 381 p. p.
24. Mwanahamuntu MH, Sahasrabuddhe VV, Pfaendler KS, Mudenda V, Hicks ML, et al. (2009) Implementation of 'see-and-treat' cervical cancer prevention services linked to HIV care in Zambia. AIDS 23: N1-5.
25. Parham GP, Sahasrabuddhe VV, Mwanahamuntu MH, Shepherd BE, Hicks ML, et al. (2006) Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia. Gynecol Oncol 103: 1017-1022.
26. Sahasrabuddhe VV, Mwanahamuntu MH, Vermund SH, Huh WK, Lyon MD, et al. (2007) Prevalence and distribution of HPV genotypes among HIV-infected women in Zambia. Br J Cancer 96: 1480-1483.
27. Chirwa S, Mwanahamuntu M, Kapambwe S, Mkumba G, Stringer J, et al. (2010) Myths and misconceptions about cervical cancer among Zambian women: rapid assessment by peer educators. Glob Health Promot 17: 47-50.
28. White HL, Mulambia C, Sinkala M, Mwanahamuntu MH, Parham GP, et al. (2012) 'Worse than HIV' or 'not as serious as other diseases'? Conceptualization of cervical cancer among newly screened women in Zambia. Soc Sci Med 74: 1486-1493.
29. Khodakarami N, Farzaneh F, Aslani F, Alizadeh K (2010) Comparison of Pap smear, visual inspection with acetic acid, and digital cervicography as cervical screening strategies. Arch Gynecol Obstet.
30. Chen ZP, Chen HM, Lee TT, (2008) Use of compact digital cervicography: an adjuvant screening tool for precancerous cervical lesions. Taiwan J Obstet Gynecol 47: 187-191.
31. Bomfim-Hyppolito S, Franco ES, Franco RG, de Albuquerque CM, Nunes GC, (2006) Cervicography as an adjunctive test to visual inspection with acetic acid in cervical cancer detection screening. Int J Gynaecol Obstet 92: 58-63.
32. Casper C, (2011) The increasing burden of HIV-associated malignancies in resource-limited regions. Annu Rev Med 62: 157-170.
33. Sylla BS, Wild CP, (2012) A million africans a year dying from cancer by 2030: what can cancer research and control offer to the continent? Int J Cancer 130: 245-250.